1. Cardiac sarcoidosis: Diagnostic, prognostic, and therapeutic considerations

   • Morie Sekiguchi
   • Yoshikazu Yazaki
   • Michiaki Hiroe

   Review Articles Pages: 495 - 510

2. Pathologic consequences of increased angiotensin II activity

   • Carlos M. Ferrario
   • John M. Flack

   Review Articles Pages: 511 - 518

3. Clinical aspects of ACE inhibition in patients with acute myocardial infarction

   • Claudio Borghi
   • Ettore Ambrosioni

   Review Articles Pages: 519 - 525

4. Radiofrequency catheter ablation of supraventricular tachycardias in patients with hypertrophic cardiomyopathy

   • Osamu Kinoshita
   • Morie Sekiguchi
   • Hiroshi Imamura

   Arrhythmias and Antiarrhythmic Drugs Pages: 527 - 530

5. Effects of AWD 23-111, a new antiarrhythmic substance, on cardiac conduction and refractoriness

   • Ulrike Stark
   • Gerhard Stark
   • Helmut A. Tritthart

   Arrhythmias and Antiarrhythmic Drugs Pages: 531 - 538

6. Assessment of frequency dependency of the class III effects of almokalant: A study using programmed stimulation and recording of monophasic action potentials and ventricular paced QT intervals

   • Börje Darpö
   • Olle Almgren
   • Nils Edvardsson

   Arrhythmias and Antiarrhythmic Drugs Pages: 539 - 547

7. Programmed ventricular stimulation after myocardial infarction does not help reduce the risk of ventricular events

   • Béatrice Brembilla-Perrot
   • Laurent Jacquemin
   • Daniel Beurrier

   Arrhythmias and Antiarrhythmic Drugs Pages: 549 - 556

8. Cytotoxicity of amiodarone in cultured human endothelial cells

   • Bruno Baudin
   • Bénédicte Bénéteau-Burnat
   • Jacqueline Giboudeau

   Arrhythmias and Antiarrhythmic Drugs Pages: 557 - 560

9. Captopril does not acutely modulate plasma endothelin-1 concentration in human congestive heart failure

   • O. Grenier
   • F. Pousset
   • M. Komajda

   Renin Angiotensin Pages: 561 - 565

10. Antioxidant status of hypercholesterolemic patients treated with LDL apheresis

    • Sylvie Lepage
    • Dominique Bonnefont-Rousselot
    • Ubald Assogba

    Lipids Pages: 567 - 571

11. Hemodynamic effects of intravenous elgodipine in coronary artery disease during rest and exercise, and basic pharmacokinetic parameters

    • Bernard Silke
    • Stephan de la Motte
    • Francisco J. Harrison

    Calcium Antagonists Pages: 573 - 580

12. Contrasting effects of betaxolol and propranolol on Ca²⁺-activated contractions in skinned fibers from canine coronary arteries and ventricular muscles

    • Yoshimi Kitada

    Beta Blockers and Calcium Pages: 581 - 586

13. Prevention by cromakalim of spontaneously occurring cardiac necroses in polymyopathic hamsters

    • Gaëtan Jasmin
    • Libuse Proschek

    Potassium Channel Opener and Cardiac Necrosis Pages: 587 - 591

14. Effect of prolonged inhibition of neutral endopeptidase on cardiac hypertrophy in rats with myocardial infarction

    • C. Marie
    • C. Mossiat
    • J. Bralet

    Neutral Endopeptidase Post Infarct Pages: 593 - 598

15. Book Review

    BookReview Pages: 599 - 599